Stock screenerAll disclosures →
EDGAR →
AZN
Conviction 66HealthcareScan · Thu, Jun 25, 2026AZN$185.74+1.49%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.03M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price185.74
Change+1.49%
Gap+0.98%
Rel volume1.85×
Avg volume2.07M
Avg $ vol373.96M
SMA 20180.61
SMA 50185.30
SMA 200139.18
Price vs 50+0.24%
Price vs 200+33.46%
MA stackbullish
50/200 cross—
Supertrenddown · 187.00
RSI (14)56
MACD hist0.78
MACD crossbull · 2d
Stoch %K / %D94 / 76
ADX (14)16
+DI / −DI31 / 27
RSI divergenceBullish
MACD divergenceBullish
ATR %+2.03%
ADR %1.64%
52w high209.48
52w low68.72
From 52w high-11.33%
Above 52w low+170.29%
New 52w highNo
SqueezeOff
Bollinger width7.50%
%B0.88
Donchian pos89.88%
Donchian high187.10
Donchian low173.66
AVWAP (52w high)190.69
vs AVWAP high-2.59%
AVWAP (52w low)107.98
vs AVWAP low+72.01%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d1.85×
Avg vol (14d)2.03M
Avg vol (20d)2.07M
Avg $ vol (20d)373.96M
Market cap277.22B
RS 3m (vs SPY)-13.74%
RS 6m (vs SPY)+92.59%
RS line new highNo
Trend template7/8
Technical rank79.8
1 week+4.41%
1 month-0.77%
3 months-0.75%
6 months+102.88%
1 year+163.31%
YTD+102.84%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target212.71
Target upside14.52%
Analyst ratingBuy
Institutional49.21%
Ent. value—
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - General
ExchangeNYSE
Shares out—
Employees96.1K
ListedFri, Oct 23, 2009
Free float1.54B
Float %99.4%
Short interest1.72M
Days to cover1.0d
Short volume47.8%
Squeeze score23 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$2.10 · 3 est
Last EPS vs est$2.58 vs $2.57
Last surprise+0.4% beat
Setup gradeB
Conviction66 / 100
Pattern quality—
Tech rank79.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance189.64
Support174.13
Days since event—
Candle confirm—
News sentiment—
Congress activity
Disclosed STOCK Act trades in AZN · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Julia Letlow house · LA · traded 2025-12-08 | Buy | $1K–$15K | 2025-12-08 | 2026-01-01 | |
Gilbert Cisneros house · CA · traded 2025-11-19 | Buy | $1K–$15K | 2025-11-19 | 2025-12-12 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Sell | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-09 | Buy | $1K–$15K | 2025-06-09 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-07-22 | Buy | $1K–$15K | 2025-07-22 | 2025-08-13 | |
Bruce Westerman house · R · AR · traded 2025-04-21 | Sell | $1K–$15K | 2025-04-21 | 2025-05-12 | |
Bruce Westerman house · R · AR · traded 2025-03-03 | Buy | $1K–$15K | 2025-03-03 | 2025-04-16 |
Insider activity
SEC Form 4 transactions in AZN · 3 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sharma Mani See Remarks · Ordinary Shares · 2026-06-08 | Grant | 1 | $180 | 2026-06-08 | 2026-06-16 |
Sharma Mani See Remarks · Ordinary Shares · 2026-05-20 | Sell | 11.89K | $2.2M | 2026-05-20 | 2026-05-22 |
Sharma Mani See Remarks · Ordinary Shares · 2026-05-06 | Grant | 1 | $186 | 2026-05-06 | 2026-05-08 |
Sharma Mani See Remarks · Ordinary Shares · 2026-04-07 | Grant | 1 | $196 | 2026-04-07 | 2026-05-08 |
SEC filings
EDGAR filings in AZN · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.